Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03651206
Title Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib (ROCSAN)
Acronym ROCSAN
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ARCAGY/ GINECO GROUP
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.